10x Genomics, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 8 →InsidersNo open-market buys. 5 insiders sold $4.6M, 14 of 22 sales on a 10b5-1 plan.→HoldersFMR 13.8%BlackRock 8.5%ARK 7.8%→PeersClosest companies: CTKB, QSI, PACB→
From the filings
Figures
- Revenue
- $616.9Mlast 12 months
- Net income
- −$75.1Mlast 12 months
- Operating cash flow
- $127.8Mlast 12 months
- Cash and equivalents
- $502.5Mat the last balance sheet
- Shares outstanding
- 127.7M shareson issue